¾ÏȯÀÚ ¼ö¸é Àå¾ÖÀÇ ¾à¹°¿ä¹ý£ºÃ¼°èÀû ¹®Çå °íÂû
Pharmacological Treatment for Sleep Disturbance in Patients with Cancer£ºA Systematic Review
±èÇÏ°æ, ±èÁ¾Èç,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇÏ°æ ( Kim Ha-Kyoung )
±¹¸³¼¿ïº´¿ø Á¤½Å°Ç°°ú
±èÁ¾Èç ( Kim Jong-Heun )
±¹¸³¾Ï¼¾ÅÍ Á¤½Å°Ç°Å¬¸®´Ð
KMID : 0368820100490010026
Abstract
¼ö¸é Àå¾Ö´Â ¾ÏȯÀÚµéÀÌ ÈçÇÏ°Ô È£¼ÒÇϸç, »îÀÇ Áú¿¡ ÀÇ¹Ì ÀÖ´Â ¿µÇâÀ» ¹ÌÄ¡´Â ¹®Á¦ÀÓ¿¡µµ ºÒ±¸ÇÏ°í, ±× µ¿¾È ÀÌ¿¡ ´ëÇÑ ÀûÀýÇÑ Áø·áÁöħÀÌ ¾ø¾ú´Ù. ÀÌ¿¡ º» ¿¬±¸¿¡¼´Â ¾ÏȯÀÚ ¼ö¸é Àå¾ÖÀÇ ¾à¹°¿ä¹ý¿¡ ´ëÇÑ ±Ù°Å¸¦ ¸¶·ÃÇÏ°íÀÚ Ã¼°èÀû °íÂûÀ» ¼öÇàÇÏ¿´´Ù. º» ¿¬±¸ÀÇ ±âÁØ¿¡ ¸Â¾Æ ¼±ÅÃµÈ ¿¬±¸ 7°³ Áß ÇöÀç ºÒ¸éÁõ¿¡ FDAÀÇ ½ÂÀÎÀ» ¹ÞÀº ¾à¹°À» ´ë»óÀ¸·Î ÇÑ °ÍÀº 3°³¿´°í, ³ª¸ÓÁö´Â Çã°¡»çÇ× ¿Ü·Î ó¹æµÇ´Â ¾à¹°µéÀ» ´ë»óÀ¸·Î ÇÑ °ÍÀ̾ú´Ù. ¶ÇÇÑ, Á¦´ë·Î °í¾ÈµÈ ¹«ÀÛÀ§ ´ëÁ¶ ½ÇÇ躸´Ù´Â ¿¹ºñ ¿¬±¸ ¼öÁØÀÇ ¿¬±¸µéÀÌ ´ëºÎºÐÀÌ¾î¼ ¿¬±¸ÀÇ ÁúÀ̳ª ±Ù°Å¼öÁØÀº ¾àÇÑ ÆíÀ̾úÀ¸¸ç, Àå±â°£ ÃßÀû °üÂûÇÑ ¿¬±¸´Â ¾ø¾ú´Ù. µû¶ó¼, ¾ÏȯÀÚ ¼ö¸é Àå¾ÖÀÇ ¾à¹°¿ä¹ý¿¡ °üÇÑ Áø·áÁöħÀ» Á¦½ÃÇϱâ À§Çؼ´Â ÇâÈÄ ´õ ¸¹Àº ¿¬±¸°¡ ¼öÇàµÉ ÇÊ¿ä°¡ ÀÖ°Ú´Ù.
Objectives: Sleep disturbance constitutes a significant and relatively common source of suffering for cancer patients. It is a challenge for oncologists to address this troubling symptom with pharmacotherapy¡¯s limited evidence base. This paper systematically reviewed the literature for evidence of pharmacological treatment of sleep disturbances in this population.
Methods: We searched international and domestic databases using the search terms¡°cancer¡±, ¡°sleep disturbance¡±, and¡°pharmacological intervention¡±, limiting the search to English- and Korean-language articles published between 1980 and 2008. Included studies were intervention studies, systematic reviews, and meta-analyses on pharmacological treatment for the sleep disturbance of adult patients suffering various medical conditions, including cancer. We graded the included studies according to Scottish Intercollegiate Guideline Network (SIGN) methodology checklists.
Results: Of the 223 studies searched, we only 7 studies met the criteria£º1 systematic review and 6 (85.7%) intervention studies. Among currently prescribed medications for sleep disturbance, only a few have been studied in patients with cancer, and their long-term follow-up data was not available.
Conclusion: Based on available literature, the evidence in favor of pharmacological treatment for sleep disturbance (in cancer patients) is weak. Further studies containing long-term follow-up data should be conducted.
Å°¿öµå
¾Ï;¼ö¸é Àå¾Ö;¾à¹°¿ä¹ý
Cancer;Sleep disturbance;Pharmacological treatment
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸